POMHS 9b - antipsychotic prescribing in people with a learning disability.
نویسندگان
چکیده
INTRODUCTION Prescribing Observatory for Mental Health (POMH-UK) runs national audit-based quality improvement programmes open to all specialist mental health services in the UK to help improve prescribing practice in discrete areas. AIMS The baseline sample and this re-audit represent the largest audits of antipsychotic prescribing in PWLD that have been conducted to date; and thus provide the most generalisable picture of such prescribing nationally. METHODOLOGY A case note audit of use of antipsychotic medication in PWLD was conducted using standard data collection tool provided by POMH-UK. Trust wide, 7 clinical teams in Essex and Bedfordshire & Luton, participated in the re-audit. Analysis and benchmarking was conducted centrally by POMH-UK and an individualised Trust report was compiled by POMH-UK for local review and consideration. STANDARDS The indication for treatment with antipsychotic medication should be documented in the clinical records (Deb 2006). The continuing need for antipsychotic medication should be reviewed at least once a year (Deb 2006). Side effects of antipsychotic medication should be reviewed at least once a year. This review should include assessment for the presence of extrapyramidal side effects (EPS), and screening for the 4 aspects of the metabolic syndrome: obesity, hypertension, impaired glucose tolerance and dyslipidaemia (NICE schizophrenia guideline update CG82, 2009). FINDINGS Out of three standards measured, Standard One maintained 100% throughout the baseline and re-audit and Standard Two achieved over 90% throughout baseline and re-audit. Standard 3 has improved from baseline to re-audit. Overall, there has been clear improvement in all 3 standards from baseline audit.
منابع مشابه
Neuroleptics, learning disability, and the community: some history and mystery.
Recent papers have again highlighted the consistently high use of neuroleptic agents among people with a learning disability, despite the lack of good evidence to support their role in this population for behaviour management and despite the risks of such medication. Evidence suggests, however, that prescribing habits have remained relatively unchanged; the reasons for this are poorly understoo...
متن کاملQuality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice
OBJECTIVES To determine the prevalence and quality of antipsychotic prescribing for people with intellectual disability (ID). DESIGN A clinical audit of prescribing practice in the context of a quality improvement programme. Practice standards for audit were derived from relevant, evidence-based guidelines, including NICE. Data were mainly collected from the clinical records, but to determine...
متن کاملMovement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study
OBJECTIVES To measure the incidence of movement side effects of antipsychotic drugs in adults with intellectual disability and compare rates with adults without intellectual disability. DESIGN Cohort study using data from The Health Improvement Network. SETTING UK primary care. PARTICIPANTS Adults with intellectual disability prescribed antipsychotic drugs matched to a control group of ad...
متن کاملStudy on the use of Antipsychotic Medication in an Intellectual Disability (ID) community caseload.
BACKGROUND People with intellectual disabilities (ID) are prescribed antipsychotic medications for different reasons; sometimes this is for a mental illness such as psychotic or affective symptoms, however antipsychotics are also used to improve behaviours that challenge, which are common in people with intellectual disabilities (ID) or autism or both. Antipsychotic medications can have many un...
متن کاملAre antipsychotic drugs the right treatment for challenging behaviour in learning disability?: The place of a randomised trial.
People with learning disability sometimes display challenging behaviour. This can be managed by use of antipsychotic medication or behavioural therapy or both. There is no solid evidence, however, that these therapies are safe and effective. A randomised controlled trial of antipsychotic medication has been proposed to deliver such evidence. However, this presents difficult issues in the ethics...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Psychiatria Danubina
دوره 23 Suppl 1 شماره
صفحات -
تاریخ انتشار 2011